Nigeria vs South-East Asia (WHO region): Number of malaria positive cases by microscopy
Nigeria
2.12 million
in 2024
South-East Asia (WHO region)
292,126
in 2021
Nigeria rank
5th
South-East Asia (WHO region) rank
8th
Number of malaria positive cases by microscopy over time
- Nigeria
- South-East Asia (WHO region)
How they compare
Nigeria currently reports 2.12 million against 292,126 in South-East Asia (WHO region), a difference of 1.83 million.
That makes Nigeria's figure about 7.2 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 7 shared years of data; in 2015 it was South-East Asia (WHO region) ahead.
Nigeria ranks 5th and South-East Asia (WHO region) ranks 8th of 99 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.08 million | 826,567 | 258,259 | Nigeria |
| 2020s | 2.44 million | 278,432 | 2.16 million | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of malaria positive cases by microscopy, Nigeria or South-East Asia (WHO region)?
- Nigeria, at 2.12 million against 292,126 in South-East Asia (WHO region) as of 2024.
- What is the difference in number of malaria positive cases by microscopy between Nigeria and South-East Asia (WHO region)?
- 1.83 million, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and South-East Asia (WHO region)?
- 7 years are reported by both, from 2015 to 2021.
- How do Nigeria and South-East Asia (WHO region) rank globally for number of malaria positive cases by microscopy?
- Nigeria ranks 5th and South-East Asia (WHO region) ranks 8th of 99 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of malaria positive cases by microscopy. Statizoid refreshes it automatically from the source and publishes the full history for both places.